Current News Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Prog... Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Prog... 2024-02-01 04:00:00 Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin 2024-02-01 04:00:00 Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review 2024-02-01 04:00:00 Safety of direct-acting oral anticoagulant (DOAC) prescribing: OpenSAFELY-TPP analysis of 20.5 million adults' electronic health records Safety of direct-acting oral anticoagulant (DOAC) prescribing: OpenSAFELY-TPP analysis of 20.5 million adults' electronic health records 2024-02-01 04:00:00 A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases 2024-02-01 04:00:00 Pagination First page « First Previous page ‹ Previous … Page 40 Page 41 Page 42 Page 43 Current page 44 Page 45 Page 46 Page 47 Page 48 … Next page Next › Last page Last »
